Accolade Inc   (ACCD)
Other Ticker:  
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services
Price: $8.4000 $-0.18 -2.098%
Day's High: $8.73 Week Perf: -6.15 %
Day's Low: $ 8.17 30 Day Perf: -11.58 %
Volume (M): 966 52 Wk High: $ 17.01
Volume (M$): $ 8,114 52 Wk Avg: $11.30
Open: $8.51 52 Wk Low: $6.33

 Market Capitalization (Millions $) 640
 Shares Outstanding (Millions) 76
 Employees 1,146
 Revenues (TTM) (Millions $) 388
 Net Income (TTM) (Millions $) -123
 Cash Flow (TTM) (Millions $) -96
 Capital Exp. (TTM) (Millions $) 13

Accolade Inc
Accolade Inc is a US-based healthcare technology company that provides personalized healthcare assistance to individuals and employees of various corporations. Founded in 2007, Accolade has established itself as a leader in providing technology-enabled healthcare solutions that improve patient outcomes and reduce healthcare costs.

The company's main objective is to provide personalized, proactive support and advocacy to its clients, which helps them navigate the complexities of the healthcare system in order to obtain optimal outcomes. To achieve this, Accolade has developed a platform that integrates various healthcare data sources to provide a complete view of each patient's healthcare history.

The company's services are primarily targeted at two groups: individuals and employees. For individuals, Accolade provides support to help them find the right doctors, schedule appointments, and manage chronic conditions. For employees, Accolade partners with corporations to provide personalized healthcare support to their employees, which helps the employees manage their health and wellness, leading to reduced absenteeism, increased productivity, and lower healthcare costs.

Accolade's solution is designed to be scalable, flexible, and easy to integrate with existing healthcare systems. It uses advanced analytics and machine learning algorithms to identify individuals who are at risk of developing chronic conditions or requiring hospitalization. By intervening early, Accolade can help prevent these conditions from worsening, which leads to lower healthcare costs for patients and employers.

In addition to its core services, Accolade also offers a range of custom solutions for employers, including integration with existing wellness and employee assistance programs, as well as customized communications and marketing materials to promote healthcare education and awareness.

Accolade has received numerous awards and recognitions for its innovative approach to healthcare, including being named one of the "World's Most Innovative Companies" by Fast Company and the "Top AI-Powered Healthcare Company" by Forbes. The company has also raised over $500 million in funding from investors, including Andreessen Horowitz and GV (Google Ventures).

Overall, Accolade is a leading healthcare technology company that is helping individuals and corporations navigate the complexities of the healthcare system to achieve better patient outcomes and lower healthcare costs. Its innovative platform and personalized, proactive approach make it an ideal partner for healthcare providers and employers looking to improve their healthcare offerings.

   Company Address: 1201 Third Avenue Seattle 98101 WA
   Company Phone Number: 926-8100   Stock Exchange / Ticker: NASDAQ ACCD
   ACCD is expected to report next financial results on April 25, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Accolade Inc

Accolade Inc Shines with Remarkable Top-line Surge in Fiscal Span Ending Nov 30, 2023

Accolade Inc: An In-Depth Analysis of Financial Performance and Industry Standing
Accolade Inc, a prominent player in the Professional Services industry, recently released its financial results for the fiscal third quarter ended November 30, 2023. The company reported a rise in earnings per share (EPS) to $-0.28, representing a significant improvement compared to the prior year quarter. Additionally, Accolade Inc witnessed an increase in revenue by 9.264% to $99.37 million, outperforming other industry contemporaries.
The positive financial performance of Accolade Inc is commendable, considering that the Professional Services industry only saw a 2.95% increase in revenue during the same period. This impressive growth in revenue places Accolade Inc ahead of its competitors in the industry. Not only did the company achieve growth on the top-line, but it also experienced improvements in EPS and net loss.

Accolade Inc

ACCD Achieves Remarkable 10.521% Revenue Growth in Second Quarter of 2024 Earnings Season

Accolade Inc: A Promising Outlook for Investors
Accolade Inc, a leading healthcare technology company, has recently released its financial results for the period ending August 31, 2023. The company's performance during this interval shows promising signs of improvement and growth, signaling a bullish outlook for investors.
For Q3 of the fiscal year 2023, Accolade Inc reported a loss per share of $-0.43, a significant improvement from the previous year's loss of $-0.66 per share. Moreover, the earnings per share (EPS) also saw an impressive increase from $-0.52 in the previous quarter. These figures indicate that Accolade Inc is moving towards profitability and strengthening its financial position.

Accolade Inc

Accolade Inc.'s Q1 2024 Report: Revenue Jumps 9.001% Yet Falls Short of Break-Even Despite Topline Advance

Accolade Inc, a leading technology-enabled healthcare provider, recently announced its financial results for the period ending May 31, 2023. Despite a year-on-year revenue advance of 9.001% to $93.23 million, the company was unable to reach break-even, resulting in a deficit per share of $-0.52. This indicates a significant increase in deficit compared to the preceding reporting period, where the company reported a deficit of $-0.41 per share. Additionally, revenue saw a decrease of -5.856% from $99.03 million.
The first quarter of 2024 proved challenging for Accolade Inc, as the company reported a net deficit of $-38.409 million, although this is substantially better than the deficit of $-342.822 million in the same period last year. This indicates the progress that the company has made in reducing its losses.


Accolade Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com